672 related articles for article (PubMed ID: 27231279)
1. Engineered cationic antimicrobial peptide (eCAP) prevents Pseudomonas aeruginosa biofilm growth on airway epithelial cells.
Lashua LP; Melvin JA; Deslouches B; Pilewski JM; Montelaro RC; Bomberger JM
J Antimicrob Chemother; 2016 Aug; 71(8):2200-7. PubMed ID: 27231279
[TBL] [Abstract][Full Text] [Related]
2. The Semi-Synthetic Peptide Lin-SB056-1 in Combination with EDTA Exerts Strong Antimicrobial and Antibiofilm Activity against Pseudomonas aeruginosa in Conditions Mimicking Cystic Fibrosis Sputum.
Maisetta G; Grassi L; Esin S; Serra I; Scorciapino MA; Rinaldi AC; Batoni G
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28926942
[No Abstract] [Full Text] [Related]
3. Dispersal of Epithelium-Associated Pseudomonas aeruginosa Biofilms.
Zemke AC; D'Amico EJ; Snell EC; Torres AM; Kasturiarachi N; Bomberger JM
mSphere; 2020 Jul; 5(4):. PubMed ID: 32669459
[No Abstract] [Full Text] [Related]
4. Activity of a novel antimicrobial peptide against Pseudomonas aeruginosa biofilms.
Beaudoin T; Stone TA; Glibowicka M; Adams C; Yau Y; Ahmadi S; Bear CE; Grasemann H; Waters V; Deber CM
Sci Rep; 2018 Oct; 8(1):14728. PubMed ID: 30283025
[TBL] [Abstract][Full Text] [Related]
5. Enhanced efficacy of the engineered antimicrobial peptide WLBU2 via direct airway delivery in a murine model of Pseudomonas aeruginosa pneumonia.
Chen C; Deslouches B; Montelaro RC; Di YP
Clin Microbiol Infect; 2018 May; 24(5):547.e1-547.e8. PubMed ID: 28882728
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms.
Sánchez-Gómez S; Ferrer-Espada R; Stewart PS; Pitts B; Lohner K; Martínez de Tejada G
BMC Microbiol; 2015 Jul; 15():137. PubMed ID: 26149536
[TBL] [Abstract][Full Text] [Related]
7. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA
J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523
[TBL] [Abstract][Full Text] [Related]
8. In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells.
Anderson GG; Moreau-Marquis S; Stanton BA; O'Toole GA
Infect Immun; 2008 Apr; 76(4):1423-33. PubMed ID: 18212077
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells.
Yu Q; Griffin EF; Moreau-Marquis S; Schwartzman JD; Stanton BA; O'Toole GA
J Antimicrob Chemother; 2012 Nov; 67(11):2673-81. PubMed ID: 22843834
[TBL] [Abstract][Full Text] [Related]
10. Sodium nitrite blocks the activity of aminoglycosides against Pseudomonas aeruginosa biofilms.
Zemke AC; Gladwin MT; Bomberger JM
Antimicrob Agents Chemother; 2015; 59(6):3329-34. PubMed ID: 25801569
[TBL] [Abstract][Full Text] [Related]
11. Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation.
Price KE; Orazi G; Ruoff KL; Hebert WP; O'Toole GA; Mastoridis P
PLoS One; 2015; 10(10):e0141192. PubMed ID: 26506004
[TBL] [Abstract][Full Text] [Related]
12. Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications.
Deslouches B; Islam K; Craigo JK; Paranjape SM; Montelaro RC; Mietzner TA
Antimicrob Agents Chemother; 2005 Aug; 49(8):3208-16. PubMed ID: 16048927
[TBL] [Abstract][Full Text] [Related]
13. Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides.
Dosler S; Karaaslan E
Peptides; 2014 Dec; 62():32-7. PubMed ID: 25285879
[TBL] [Abstract][Full Text] [Related]
14. Combination of hypothiocyanite and lactoferrin (ALX-109) enhances the ability of tobramycin and aztreonam to eliminate Pseudomonas aeruginosa biofilms growing on cystic fibrosis airway epithelial cells.
Moreau-Marquis S; Coutermarsh B; Stanton BA
J Antimicrob Chemother; 2015 Jan; 70(1):160-6. PubMed ID: 25213272
[TBL] [Abstract][Full Text] [Related]
15.
Kiedrowski MR; Gaston JR; Kocak BR; Coburn SL; Lee S; Pilewski JM; Myerburg MM; Bomberger JM
mSphere; 2018 Aug; 3(4):. PubMed ID: 30111629
[No Abstract] [Full Text] [Related]
16. Bacterial cis-2-unsaturated fatty acids found in the cystic fibrosis airway modulate virulence and persistence of Pseudomonas aeruginosa.
Twomey KB; O'Connell OJ; McCarthy Y; Dow JM; O'Toole GA; Plant BJ; Ryan RP
ISME J; 2012 May; 6(5):939-50. PubMed ID: 22134647
[TBL] [Abstract][Full Text] [Related]
17. The DeltaF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability.
Moreau-Marquis S; Bomberger JM; Anderson GG; Swiatecka-Urban A; Ye S; O'Toole GA; Stanton BA
Am J Physiol Lung Cell Mol Physiol; 2008 Jul; 295(1):L25-37. PubMed ID: 18359885
[TBL] [Abstract][Full Text] [Related]
18. In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients.
Fernández-Olmos A; García-Castillo M; Maiz L; Lamas A; Baquero F; Cantón R
Int J Antimicrob Agents; 2012 Aug; 40(2):173-6. PubMed ID: 22727530
[TBL] [Abstract][Full Text] [Related]
19. Pseudomonas aeruginosa Increases the Sensitivity of Biofilm-Grown Staphylococcus aureus to Membrane-Targeting Antiseptics and Antibiotics.
Orazi G; Ruoff KL; O'Toole GA
mBio; 2019 Jul; 10(4):. PubMed ID: 31363032
[No Abstract] [Full Text] [Related]
20. Enhancement of antimicrobial activity against pseudomonas aeruginosa by coadministration of G10KHc and tobramycin.
Eckert R; Brady KM; Greenberg EP; Qi F; Yarbrough DK; He J; McHardy I; Anderson MH; Shi W
Antimicrob Agents Chemother; 2006 Nov; 50(11):3833-8. PubMed ID: 16940063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
